Editpep
Tuesday, February 27, 2024
Plymouth
CNS/Neurological
Editpep produces CRISPR based therapeutics by leveraging the Transporter peptide based delivery platform, focusing on CNS and eye indications.
Speakers
State
CA
Country
United States
Website
https://www.editpep.bio/
CEO/Top Company Official
Genine Winslow
Lead Product in Development
Dravet Syndrome, CNS delivery
Development Phase of Primary Product
Pre-Clinical
Number Of Unlicensed Products
2
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}